Ohio SB227 limits cost sharing for prescription insulin drugs to $35 per 30-day supply.
Ohio SB227 amends the state's Revised Code to cap cost sharing for prescription insulin drugs at $35 per 30-day supply. This applies to all health plans amended, issued, or renewed after the bill's effective date. The cap applies regardless of the amount or type of insulin needed to fill a prescription. This change aims to make insulin more affordable for individuals with diabetes in Ohio.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.